2026 Semifinalists

2026

President’s Innovation Challenge

Out of 400+ applications, we've selected 180+ PIC semifinalists. These ventures represent all 13 Harvard schools and are one step closer to winning a share of $500,000+ in Bertarelli Foundation funding.

pic finalist gif

An internal PIC selection committee reviews initial venture applications and selects the semifinalists.

Industry

Program

School

Clear all filters

HarborSite

Developing a next-generation gene insertion platform for the treatment of genetic and age-associated diseases.
Linton Lifesciences

Using 3D bioprinting to create custom arteries for bypass surgery, aiming to replace traditional autologous grafts.
NanoDEX

Accelerating drug discovery by leveraging nanopore technology to target previously challenging proteins.
NuCyRNA Therapeutics

Redefining RNA-targeting therapeutics, starting in neurodegenerative diseases.
PieD

Developing an AI-powered wearable photonic device for at-home heart failure monitoring through real-time, multi-biomarker detection.
Procure Bio

Engineering protein nanoparticles for targeted delivery of gene and protein therapeutics, advancing novel treatments for genetic diseases.
Promakhos Therapeutics Inc.

Developing oral, non-immunosuppressive, small molecules to cure chronic inflammatory disorders.
Salience

Enabling high-bandwidth human–AI collaboration by allowing agents to understand user intent beyond text and command-based interactions.